The first company to commercialize a full-field digital mammography system and the first to deliver mammography CAD have renewed their alliance. GE Medical Systems (Waukesha, WI) and R2 Technology (Sunnyvale, CA) announced Dec. 12 that R2's ImageChecker
The first company to commercialize a full-field digital mammography system and the first to deliver mammography CAD have renewed their alliance. GE Medical Systems (Waukesha, WI) and R2 Technology (Sunnyvale, CA) announced Dec. 12 that R2's ImageChecker CAD system would continue to be distributed with GE's Senographe 2000D full-field digital mammography system. More than 100 such combinations are already operating in clinical sites, according to GE, and there is room for substantial growth. More than 550 Senographe 2000D systems have been installed in the U.S., and all are upgradable to R2's CAD technology. The FDA originally cleared the ImageChecker system in 1998 for use with film-based screening mammography to assist radiologists in minimizing false-negative readings. Supplemental approvals by the FDA allowed the technology to be used in combination with the Senographe 2000D.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.